18F-92

N/A

Report date: 2025/11/25 15:52:47

Base Information

Drug Name18F-92

Drug Alias Name18F-92

ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4]

Mechanisms of ActionBeta amyloid A4 protein modulatorsPositron-emission tomography enhancers

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesFirst Affiliated Hospital Of Fujian Medical University

China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Fujian Medical University

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A